Penumbra Inc (PEN) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally.

Total Cash From Operating Activities Chart for Penumbra Inc

Penumbra Inc (PEN) operating cash flow for FY2025 was USD 238.7M, a 41.7% change from FY2024. Penumbra Inc's operating cash flow moved from USD -3.4M in 2013 to USD 238.7M in 2025 over 12 years.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Cash From Operating Activities (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$12.49B
Implied Share Price
$317.05
Enterprise Value
$12.14B
Revenue (TTM)
$1.50B
EBITDA
$204.28M
Profit Margin
10.67%
Trailing P/E
77.90
Forward P/E
55.56
Price/Book (MRQ)
8.22
Price/Sales (TTM)
8.30
EV/EBITDA
54.60
EV/Revenue
8.06
Dividend Yield
—
Book Value
$38.86
Free Cash Flow (FY2025)
$174.93M
Free Cash Flow Yield
1.40%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.